Recruiting Interstitial Lung Disease Studies in Philadelphia
About Interstitial Lung Disease Clinical Trials in Philadelphia
Interstitial lung disease is a group of disorders characterized by progressive scarring of lung tissue, leading to breathlessness and reduced oxygen exchange. Causes include autoimmune diseases, environmental exposures, and unknown factors. Treatment includes antifibrotic medications and immunosuppressants.
There are currently 18 interstitial lung disease clinical trials recruiting participants in Philadelphia, PA. These studies are seeking a combined 18,155 participants. Research is being sponsored by Boston Children's Hospital, University of California, Davis, University of North Carolina, Chapel Hill and 9 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Interstitial Lung Disease Clinical Trials in Philadelphia — FAQ
Are there interstitial lung disease clinical trials in Philadelphia?
Yes, there are 18 interstitial lung disease clinical trials currently recruiting in Philadelphia, PA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Philadelphia?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.
Are clinical trials in Philadelphia free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.
What interstitial lung disease treatments are being tested?
The 18 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial lung disease.
Data updated July 13, 2026 from ClinicalTrials.gov